<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02010723</url>
  </required_header>
  <id_info>
    <org_study_id>20060508</org_study_id>
    <secondary_id>255/2006</secondary_id>
    <nct_id>NCT02010723</nct_id>
  </id_info>
  <brief_title>Surgery Versus Sclerotherapy for Isolated Accessory Great Saphenous Vein Varicosis</brief_title>
  <official_title>Comparison of Surgery Versus Foam Sclerotherapy for Isolated Accessory Great Saphenous Vein Varicosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two therapeutic procedures in the treatment of
      isolated varicosis of the anterior accessory great saphenous vein (AAGSV): crossectomy and
      avulsion of the varicose AAGSV versus foam sclerotherapy of the AAGSV.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>duplex-sonographic recurrence after 3 years</measure>
    <time_frame>3 years</time_frame>
    <description>duplex-sonographic recurrence is defined as reverse blood flow of &gt; 0.5 sec along the anterior accessory great saphenous vein (AAGSV) in the sclerotherapy group or in new anterior thigh varicosities connected to the previous saphenofemoral junction (NATV) in the surgical group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>duplex-sonographic recurrence after 1 year</measure>
    <time_frame>1 year</time_frame>
    <description>duplex-sonographic recurrence is defined as reverse blood flow of &gt; 0.5 sec along the AAGSV in the sclerotherapy group or in new anterior thigh varicosities connected to the previous saphenofemoral junction (NATV) in the surgical group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>clinical recurrence</measure>
    <time_frame>1 year and 3 years</time_frame>
    <description>Clinical recurrence is evaluated by determination of the current Clinical-Etiology- Anatomy- Pathophysiology (CEAP) classification and reappearance of new varicose veins in the treated area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neovascularisation in the saphenofemoral junction</measure>
    <time_frame>1 year and 3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Varicose Veins</condition>
  <arm_group>
    <arm_group_label>surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>crossectomy and avulsion of the varicose anterior accessory great saphenous vein (AAGSV) under local anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sclerotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>foam sclerotherapy with aethoxysclerol foam</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>surgery</intervention_name>
    <description>crossectomy and avulsion of the varicose anterior accessory great saphenous vein (AAGSV) under local anesthesia</description>
    <arm_group_label>surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sclerotherapy with aethoxysclerol foam</intervention_name>
    <description>foam sclerotherapy with aethoxysclerol foam</description>
    <arm_group_label>sclerotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  reflux in anterior accessory great saphenous vein (AAGSV) &gt; 0,5 sek

        Exclusion Criteria:

          -  concomitant reflux in great saphenous vein (GSV)

          -  reflux in the deep venous system (postthrombotic syndrome)

          -  acute thrombosis

          -  hypercoagulability

          -  allergy to aethoxysclerol or local anesthetics

          -  immobility

          -  open foramen ovale

          -  bacterial infection of the skin

          -  pregnancy and breast feeding

          -  peripheral arterial occlusive disease III, IV (PAOD)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kornelia Boehler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna, University Clinic of Dermatology, Department of General Dermatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna, Department of General Dermatology</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Prinz N, Selzle K, Kamionek I, Sagoo KS, Leberig A, Kaiser R, Schonath M. [Surgery of the lateral accessory saphenous vein]. Zentralbl Chir. 2001 Jul;126(7):526-7. German.</citation>
    <PMID>11503465</PMID>
  </reference>
  <reference>
    <citation>Breu FX, Guggenbichler S, Wollmann JC; Second European Consensus Meeting on Foam Sclerotherapy. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. Vasa. 2008 Feb;37(1):90-5.</citation>
    <PMID>18512547</PMID>
  </reference>
  <reference>
    <citation>Theivacumar NS, Darwood RJ, Gough MJ. Endovenous laser ablation (EVLA) of the anterior accessory great saphenous vein (AAGSV): abolition of sapheno-femoral reflux with preservation of the great saphenous vein. Eur J Vasc Endovasc Surg. 2009 Apr;37(4):477-81. doi: 10.1016/j.ejvs.2008.11.035. Epub 2009 Feb 7.</citation>
    <PMID>19201621</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2013</study_first_submitted>
  <study_first_submitted_qc>December 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2013</study_first_posted>
  <last_update_submitted>December 12, 2013</last_update_submitted>
  <last_update_submitted_qc>December 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Kornelia Boehler</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>varicosis</keyword>
  <keyword>foam sclerotherapy</keyword>
  <keyword>surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polidocanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

